Departments of Radiology and Nuclear Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Eur Radiol. 2010 Dec;20(12):2959-72. doi: 10.1007/s00330-010-1862-z. Epub 2010 Jun 25.
Hybrid imaging with combined positron emission tomography/computed tomography (PET/CT) plays an important role in the staging and management of a wide variety of solid tumours. However, its use in the evaluation of musculoskeletal malignancy has not yet entered routine clinical practice. Cross-sectional imaging with magnetic resonance imaging (MR) and computed tomography have well-established roles but there is increasing evidence for the selective use of PET/CT in the management of these patients. The aims of this article are to review the current evidence and clinical applications of PET/CT in primary musculoskeletal tumours and discuss potential future developments using novel PET tracers and integrated PET/MR.
正电子发射断层扫描/计算机断层扫描（PET/CT）的混合成像在各种实体瘤的分期和治疗中发挥着重要作用。然而，它在肌肉骨骼恶性肿瘤评估中的应用尚未进入常规临床实践。磁共振成像（MR）和计算机断层扫描的横断面成像具有明确的作用，但越来越多的证据表明 PET/CT 在这些患者的治疗中有选择地使用。本文的目的是回顾 PET/CT 在原发性肌肉骨骼肿瘤中的当前证据和临床应用，并讨论使用新型 PET 示踪剂和集成 PET/MR 的潜在未来发展。
